pharmaceutical industry
Tom Price's stock deals resurrect concerns about powerful public officials gaining investment opportunities unavailable to the public.
A small win in a losing war against soaring drug prices.
13 Democrats did the industry's bidding last night.
"These people are horrific," the senator said.
WHAT'S HAPPENING
Rep. Tom Price worked hard to keep federal dollars flowing to his most generous campaign donors.
The pharmaceuticals industry may be slowing down again.
The discount comes after a government investigation into EpiPen's 2008 price hike.
Pharmaceutical stocks took a hit after his statements.
The President-elect's "vicious" Tweets have business leaders on edge.
An Obama initiative to hold the line on spending has run into a lobbying buzzsaw.